… Extracorporeal photopheresis (ECP) is an established treatment … This study's main objective
was to analyze the clinical … This multicenter observational retrospective study was conducted …

Extracorporeal photopheresis (ECP) has been in clinical use … will be discussed in this review.
A trend toward prophylactic … The aim of this review is to (1) introduce the method, (2) give …

… retrospective, 4-36 and very few data are published on the use and results of ECP in real-life.
The aim of this multicenter retrospective observational Italian study … a retrospective study on …

Background Extracorporeal photopheresis (ECP) is recommended as a second- or later-line
therapy for chronic GvHD (cGvHD). Benefits include reasonable response with avoidance …

… Single-center studies have suggested extracorporeal photopheresis (ECP) using UV-A …
In the present study, we performed a retrospective comparison of the efficacy of second-line …

… Extracorporeal photopheresis (ECP) is a recommended second or later line of therapy for …
In this single centre study, we attempted to evaluate not only therapeutic efficacy of ECP, but …

… Retrospective studies have indicated that ECP primarily stabilizes BO [21, 22] and is insufficient
to render CR in these patients. Recently Lucid et al. [22] reported the outcome following …

… A retrospective review of 14 patients with BO(S) demonstrated the benefit of ECP in
treating low-grade BO(S) and in reversing acute rejection. These data indicate that ECP is a …

Background Extracorporeal photopheresis (ECP) is associated with few adverse effects. We
have anecdotally noted patients treated with long‐term ECP develop iron deficiency anemia …

… Extracorporeal photopheresis (ECP) is an immunomodulatory … This retrospective analysis
reports our experience using … This retrospective analysis reports our experience using ECP to …